help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2009-0346
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Rivers, C.
Right arrow Articles by Norman, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivers, C.
Right arrow Articles by Norman, M.
Endocrinology Vol. 150, No. 11 4958-4967
Copyright © 2009 by The Endocrine Society

Characterization of Conserved Tandem Donor Sites and Intronic Motifs Required for Alternative Splicing in Corticosteroid Receptor Genes

Caroline Rivers1, Andrea Flynn1, Xiaoxiao Qian, Laura Matthews, Stafford Lightman, David Ray and Michael Norman

Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology (C.R., A.F., X.Q., S.L., M.N.), University of Bristol, Bristol BS1 3NY, United Kingdom; and Endocrine Sciences Research Group (L.M., D.R.), University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 PT, United Kingdom

Address all correspondence and requests for reprints to: Michael Norman, Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Division of Medicine, University of Bristol, Bristol BS1 3NY, United Kingdom. E-mail: m.r.norman{at}bris.ac.uk.

Alternative splicing events from tandem donor sites result in mRNA variants coding for additional amino acids in the DNA binding domain of both the glucocorticoid (GR) and mineralocorticoid (MR) receptors. We now show that expression of both splice variants is extensively conserved in mammalian species, providing strong evidence for their functional significance. An exception to the conservation of the MR tandem splice site (an A at position +5 of the MR+12 donor site in the mouse) was predicted to decrease U1 small nuclear RNA binding. In accord with this prediction, we were unable to detect the MR+12 variant in this species. The one exception to the conservation of the GR tandem splice site, an A at position +3 of the platypus GR{gamma} donor site that was predicted to enhance binding of U1 snRNA, was unexpectedly associated with decreased expression of the variant from the endogenous gene as well as a minigene. An intronic pyrimidine motif present in both GR and MR genes was found to be critical for usage of the downstream donor site, and overexpression of TIA1/TIAL1 RNA binding proteins, which are known to bind such motifs, led to a marked increase in the proportion of GR{gamma} and MR+12. These results provide striking evidence for conservation of a complex splicing mechanism that involves processes other than stochastic spliceosome binding and identify a mechanism that would allow regulation of variant expression.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society